Overview
Wellysa is a health assistant application that creates personalized medical and preventive profiles for users, helping them detect health risks early. It provides access to specialized diagnostic tests and expert interpretations, focusing on cardiovascular and oncological prevention. The service is designed to complement traditional healthcare by supporting users in implementing preventive measures.
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-11-04. Active
74 1090 1056 0000 0001 5076 7753- 27 1090 1056 0000 0001 5893 0470
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 17, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $3,128$3,128 | Fundacja Koalicji na Rzecz Polskich Innowacji | |
| Jan 15, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,904$1,904 | Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk |
Tenders
No recorded participation in tenders.
Trademarks
Wellysa holds 1 active trademark registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2024.
| Mark | Protected until | |
|---|---|---|
| ONKORADAR Wellysa & Read-Gene | Jul 8, 2034 | |
| ONKORADAR | – |
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations on behalf of the company are made by one member of the management board. In the case of a multi-member management board, two members acting jointly are authorised to make declarations of will and represent the company.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Grupa Medycyna PolskaS.A. | $16,534.99 | medycynapolska.pl | ||
| Drdatesp. z o.o. | $2,940.28 | drdate.eu | ||
| Medic Gosp. z o.o. | $1,627.05 | medicgo.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-03 | Share capital change (1,177,771.98 PLN → 1,677,773.02 PLN) | |
| 2024-11-21 | Address change (Ul. Grójecka 22/24/32, 02-109, Warszawa → Ul. Grójecka 22/24/32, 02-301, Warszawa) | |
| 2024-11-21 | Share capital change (1,104,087.74 PLN → 1,177,771.98 PLN) | |
| 2024-08-12 | Share capital change (1,104,087.77 PLN → 1,104,087.74 PLN) | |
| 2024-07-22 | Share capital change (1,001,956.51 PLN → 1,104,087.77 PLN) |
FAQ
Last updated: 2026-07-16